AAAAAA

   
Results: 1-10 |
Results: 10
Cocaine use, hypertension, and end-stage renal disease
Authors: Norris, KC Thornhill-Joynes, M Robinson, C Strickland, T Alperson, BL Witana, SC Ward, HJ
Citation: Kc. Norris et al., Cocaine use, hypertension, and end-stage renal disease, AM J KIDNEY, 38(3), 2001, pp. 523-528
Efficacy and side effects of intermittent intravenous and oral doxercalciferol (1 alpha-hydroxyvitamin D-2) in dialysis patients with secondary hyperparathyroidism: A sequential comparison
Authors: Maung, HM Elangovan, L Frazao, JM Bower, JD Kelley, BJ Acchiardo, SR Rodriguez, HJ Norris, KC Sigala, JF Rutkowski, M Robertson, JA Goodman, WG Levine, BS Chesney, RW Mazess, RB Kyllo, DM Douglass, LL Bishop, CW Coburn, JW
Citation: Hm. Maung et al., Efficacy and side effects of intermittent intravenous and oral doxercalciferol (1 alpha-hydroxyvitamin D-2) in dialysis patients with secondary hyperparathyroidism: A sequential comparison, AM J KIDNEY, 37(3), 2001, pp. 532-543
Cocaine use and chronic renal failure
Authors: Norris, KC Thornhill-Joynes, M Tareen, N
Citation: Kc. Norris et al., Cocaine use and chronic renal failure, SEM NEPHROL, 21(4), 2001, pp. 362-366
Avoiding the risks of secondary hyperparathyroidism in chronic renal failure: A new approach, and a review
Authors: Norris, KC
Citation: Kc. Norris, Avoiding the risks of secondary hyperparathyroidism in chronic renal failure: A new approach, and a review, DIALYSIS T, 30(6), 2001, pp. 355
Neonatal lead poisoning from maternal pica behavior during pregnancy
Authors: Hamilton, S Rothenberg, SJ Khan, FA Manalo, M Norris, KC
Citation: S. Hamilton et al., Neonatal lead poisoning from maternal pica behavior during pregnancy, J NAT MED A, 93(9), 2001, pp. 317-319
Intermittent doxercalciferol (1 alpha-hydroxyvitamin D-2) therapy for secondary hyperparathyroidism
Authors: Frazao, JM Elangovan, L Maung, HM Chesney, RW Acchiardo, SR Bower, JD Kelley, BJ Rodriguez, HJ Norris, KC Robertson, JA Levine, BS Goodman, WG Gentile, D Mazess, RB Kyllo, DM Douglass, LL Bishop, CW Coburn, JW
Citation: Jm. Frazao et al., Intermittent doxercalciferol (1 alpha-hydroxyvitamin D-2) therapy for secondary hyperparathyroidism, AM J KIDNEY, 36(3), 2000, pp. 550-561
Internet access and use among disadvantaged inner-city patients
Authors: Robinson, C Flowers, CW Alperson, BL Norris, KC
Citation: C. Robinson et al., Internet access and use among disadvantaged inner-city patients, J AM MED A, 281(11), 1999, pp. 988-989
Secondary hyperparathyroidism: Defining a model of optimal management
Authors: Norris, KC
Citation: Kc. Norris, Secondary hyperparathyroidism: Defining a model of optimal management, DIALYSIS T, 28(11), 1999, pp. 630
A test of a pattern recognition system for identification of spiders
Authors: Do, MT Harp, JM Norris, KC
Citation: Mt. Do et al., A test of a pattern recognition system for identification of spiders, B ENT RES, 89(3), 1999, pp. 217-224
Toward a new treatment paradigm for hyperphosphatemia in chronic renal disease
Authors: Norris, KC
Citation: Kc. Norris, Toward a new treatment paradigm for hyperphosphatemia in chronic renal disease, DIALYSIS T, 27(12), 1998, pp. 767
Risultati: 1-10 |